Cargando…
Persistence With Biologic Therapy and Associated Costs of Patients With Inflammatory Bowel Disease: A German Retrospective Claims Data Analysis
BACKGROUND: In recent years, biologic agents became a relevant and promising treatment option for inflammatory bowel diseases (IBDs). However, high treatment costs and moderate remission rates lead to a high interest in treatment persistence and corresponding economic consequences. METHODS: A retros...
Autores principales: | Mahlich, Joerg, May, Melanie, Feig, Chiara, Straub, Vincent, Schmelz, Renate |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802337/ https://www.ncbi.nlm.nih.gov/pubmed/36778945 http://dx.doi.org/10.1093/crocol/otab011 |
Ejemplares similares
-
Treatment Pathways and Health Outcomes of German Patients with Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Health Claims Data Analysis
por: Scheid, Christof, et al.
Publicado: (2022) -
Real-World Persistency for Inflammatory Bowel Disease Biologics Using Patient Registry Data
por: Goss Sawhney, Tia, et al.
Publicado: (2023) -
Human Papillomavirus Type 16 Circular RNA Is Barely Detectable for the Claimed Biological Activity
por: Yu, Lulu, et al.
Publicado: (2022) -
Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database
por: Sruamsiri, Rosarin, et al.
Publicado: (2018) -
Extraintestinal Manifestations of Inflammatory Bowel Disease Are Associated With Increased Biologic Cycling
por: Alizadeh, Madeline, et al.
Publicado: (2023)